Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy

Authors

Raj Ramakrishna, University of WollongongFollow
Terrence H. Diamond, St. George HospitalFollow
William Alexander, University of Wollongong
Arumugam Manoharan, University of WollongongFollow
Terry Golombick, St. George HospitalFollow

RIS ID

142653

Publication Details

Ramakrishna, R., Diamond, T. H., Alexander, W., Manoharan, A. & Golombick, T. (2020). Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy. Clinical Case Reports, 8 (4), 739-744.

Abstract

Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression-free survival without the adverse effects of steroid-based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.